Alimera Sciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.40
|
-0.75
|
-0.35
|
-87.50%
|
|
2022-06-30
|
-0.55
|
-0.45
|
0.10
|
18.18%
|
|
2022-03-31
|
-0.69
|
-0.85
|
-0.16
|
-23.19%
|
|
2021-12-31
|
-0.42
|
-0.59
|
-0.17
|
-40.48%
|
|
2021-09-30
|
-0.52
|
-0.60
|
-0.08
|
-15.38%
|
|
2021-06-30
|
1.06
|
1.03
|
-0.03
|
-2.83%
|
|
2021-03-31
|
-0.54
|
-0.63
|
-0.09
|
-16.67%
|
|
2020-12-31
|
-0.04
|
-0.18
|
-0.14
|
-350.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.05
|
|
2021-12-31
|
-0.79
|
|
2020-12-31
|
-1.05
|
|
2019-12-31
|
-2.17
|
|
2018-12-31
|
3.00
|
|
2017-12-31
|
-1.72
|
|
2016-12-31
|
-0.65
|
|
2015-12-31
|
-0.68
|
|
2014-12-31
|
-2.80
|
|
2013-12-31
|
-18.75
|
|
2012-12-31
|
-9.45
|
|
2011-12-31
|
-10.80
|
|
2010-12-31
|
-75.60
|